Related Experiment Video
Updated: May 24, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
An insight into the new anticonvulsant agents
Waquar Ahsan1, Mohsin M Safhi, Nadeem Siddiqui
1Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, Jazan, KSA.
New anticonvulsant agents show promise for treating epilepsy with improved efficacy and reduced side effects compared to current antiepileptic drugs. These novel compounds offer potential as lead molecules for future epilepsy drug development.
Area of Science:
- Pharmacology and Neuroscience
- Medicinal Chemistry
Background:
- Current antiepileptic drugs (AEDs) face challenges due to nonselectivity and adverse side effects.
- This has prompted extensive global research into novel anticonvulsant therapies over the last decade.
Purpose of the Study:
- To review emerging anticonvulsant agents with promising efficacy and reduced neurotoxicity.
- To provide a structural classification of active compounds and discuss their potential as future drug candidates.
Main Methods:
- Literature review of recent studies on novel anticonvulsant agents.
- Analysis of pharmacological and pathophysiological data for different epilepsy types.
- Structural classification of the most active compounds.
Main Results:
- Several new anticonvulsant agents demonstrate encouraging activity.
- These agents exhibit potentially lower neurotoxicity compared to existing AEDs.
- Promising outcomes regarding both drug efficacy and safety have been reported.
Conclusions:
- Novel structural classes of anticonvulsant compounds are identified.
- These compounds represent promising lead molecules for further investigation in epilepsy treatment.
- The findings suggest a positive outlook for developing safer and more effective epilepsy medications.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...

